Shen, X., Moodie, Z., McMillan, A., Goodman, D., Yates, N., Spreng, R., … Tomaras, G. (2018). V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 34, pp. 17–17). Madrid, SPAIN: MARY ANN LIEBERT, INC.

Shen, Xiaoying, Zoe Moodie, Arthur McMillan, Derrick Goodman, Nicole Yates, Rachel Spreng, Nicole Grunenberg, et al. “V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 34:17–17. MARY ANN LIEBERT, INC, 2018.

Shen X, Moodie Z, McMillan A, Goodman D, Yates N, Spreng R, et al. V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 17–17.

Shen, Xiaoying, et al. “V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 34, MARY ANN LIEBERT, INC, 2018, pp. 17–17.

Shen X, Moodie Z, McMillan A, Goodman D, Yates N, Spreng R, Grunenberg N, Gilbert P, Phogat S, Diazgranados C, Laher F, Bekker L-G, Gray G, Corey L, McElrath J, Ferrari G, Tomaras G. V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 17–17.